Valiant Laboratories Chandrakant Vallabhaji Gogri steps down
Valiant Laboratories (VALIANTLAB) said Chandrakant Vallabhaji Gogri has ceased. The company is valued at about ₹570 crore.
What happened
Valiant Laboratories (VALIANTLAB) told the exchanges on 15 November 2026 at 10:32 PM that Chandrakant Vallabhaji Gogri has ceased.
From the filing: "the member of a Promoter Group of the Company With profound grief, we inform you of the demise of Shri Chandrakant Vallabhaji Gogri, a member of the Promoter Group of the Company, today, i.e., Sunday, November 15, 2026."
Company snapshot
Valiant Laboratories is a micro-cap company, with a market value of about ₹570 crore.
The stock last traded at ₹105, against a 52-week range of ₹49.51–₹141.4 (25.8% below the high).
Before this filing the shares had moved −14.3% over the month and +27.4% over three months. Average daily turnover over the last 20 sessions was about ₹0.5 crore.
Promoters held 74.94% at the end of Q2 FY27. Foreign institutions owned 0.07% and domestic institutions 0.08%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 46 | 0.2 | 0.04 |
| Q3 FY26 | 52 | -7.1 | -1.3 |
| Q4 FY26 | 92 | 1.8 | 0.32 |
| Q1 FY27 | 115 | 21.1 | 3.89 |
| Q2 FY27 | 117 | 0.4 | 0.08 |
What history shows
BCEIE's records show 1 previous management change filing from the company since May 2026.
Market-wide, 4,563 management change filings with an impact score of 50 or more saw an average next-day move of −0.0%, with 46% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.